An HIV vaccine--challenges and prospects
- PMID: 18753644
- DOI: 10.1056/NEJMp0806162
An HIV vaccine--challenges and prospects
Similar articles
-
Molecular snapshots from CROI 2007.IAVI Rep. 2007 Jan-Feb;11(1):1, 6-9. IAVI Rep. 2007. PMID: 20213873 No abstract available.
-
Challenges and opportunities for development of an AIDS vaccine.Nature. 2001 Apr 19;410(6831):1002-7. doi: 10.1038/35073500. Nature. 2001. PMID: 11309631 Review.
-
Grim news for vaccine.AIDS Patient Care STDS. 2002 Oct;16(10):513-4. AIDS Patient Care STDS. 2002. PMID: 12442739 No abstract available.
-
HIV vaccine may raise risk.Nature. 2007 Nov 15;450(7168):325. doi: 10.1038/450325a. Nature. 2007. PMID: 18004331 No abstract available.
-
CTL ontogeny and viral escape: implications for HIV-1 vaccine design.Trends Immunol. 2004 Mar;25(3):138-42. doi: 10.1016/j.it.2004.01.004. Trends Immunol. 2004. PMID: 15036041 Review. No abstract available.
Cited by
-
A randomized trial of enhanced HIV risk-reduction and vaccine trial education interventions among HIV-negative, high-risk women who use noninjection drugs: the UNITY study.J Acquir Immune Defic Syndr. 2010 Mar;53(3):378-87. doi: 10.1097/QAI.0b013e3181b7222e. J Acquir Immune Defic Syndr. 2010. PMID: 20190585 Free PMC article. Clinical Trial.
-
Two closely related Env antigens from the same patient elicited different spectra of neutralizing antibodies against heterologous HIV-1 isolates.J Virol. 2011 May;85(10):4927-36. doi: 10.1128/JVI.00081-11. Epub 2011 Mar 16. J Virol. 2011. PMID: 21411542 Free PMC article.
-
HIV-1 neutralizing antibodies: understanding nature's pathways.Immunol Rev. 2013 Jul;254(1):225-44. doi: 10.1111/imr.12075. Immunol Rev. 2013. PMID: 23772623 Free PMC article. Review.
-
Topical application of entry inhibitors as "virustats" to prevent sexual transmission of HIV infection.Retrovirology. 2008 Dec 18;5:116. doi: 10.1186/1742-4690-5-116. Retrovirology. 2008. PMID: 19094217 Free PMC article. Review.
-
Feasibility of Identifying a Female Sex Worker Cohort at High Risk of HIV Infection in the Caribbean for HIV Vaccine Efficacy Trials: Longitudinal Results of HVTN 907.J Acquir Immune Defic Syndr. 2016 Jan 1;71(1):70-7. doi: 10.1097/QAI.0000000000000796. J Acquir Immune Defic Syndr. 2016. PMID: 26761272 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical